| dc.creator |
Kale Koroglu, Banu |
|
| dc.creator |
Ersoy, Ismail Hakki |
|
| dc.creator |
Akin, Mete |
|
| dc.creator |
Koroglu, Mert |
|
| dc.creator |
Songur, Yildiran |
|
| dc.creator |
Tamer, M. Numan |
|
| dc.date |
2012-05-31T21:00:00Z |
|
| dc.date.accessioned |
2020-10-06T11:01:41Z |
|
| dc.date.available |
2020-10-06T11:01:41Z |
|
| dc.identifier |
b76815b3-f496-47fd-ae79-972cd6899c81 |
|
| dc.identifier |
10.5336/medsci.2010-20920 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/b76815b3-f496-47fd-ae79-972cd6899c81/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/70184 |
|
| dc.description |
Acute pancreatitis is the rapid onset inflammation of the pancreas. Medications are rare but important and rising cause of acute pancreatitis and account for approximately 2% of all cases. Sitagliptin is a potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of patients with type 2 diabetes mellitus and acts by increasing active incretin hormone concentrations. Adverse effects including constipation, nausea, nasopharyngitis, urinary tract infection and dizziness were reported. We reported a case with acute pancreatitis that seems to be induced by sitagliptin. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Sitagliptin and Acute Pancreatitis: Cases and Literature Review |
|
| dc.type |
info:eu-repo/semantics/article |
|